Doximity, Inc. (DOCS)
Market Cap | 11.99B |
Revenue (ttm) | 589.64M |
Net Income (ttm) | 235.13M |
Shares Out | 187.30M |
EPS (ttm) | 1.17 |
PE Ratio | 54.76 |
Forward PE | 41.94 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,770,393 |
Open | 62.00 |
Previous Close | 61.82 |
Day's Range | 61.88 - 64.73 |
52-Week Range | 34.34 - 85.21 |
Beta | 1.36 |
Analysts | Buy |
Price Target | 66.74 (+4.25%) |
Earnings Date | Aug 7, 2025 |
About DOCS
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, ... [Read more]
Financial Performance
In 2024, Doximity's revenue was $570.40 million, an increase of 19.98% compared to the previous year's $475.42 million. Earnings were $223.19 million, an increase of 51.23%.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $66.74, which is an increase of 4.25% from the latest price.
News

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Per...

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said.

Doximity Acquires Pathway, a Leader in AI Clinical Reference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based st...

Doximity Announces Fiscal 2026 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. ...

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight ...

Doximity: Slowing Sales And EBITDA Growth
Doximity shares have dropped nearly 25% from February highs, despite strong Q4 earnings and 17% revenue growth year-over-year. Analyst sentiment is mixed, and insider selling has notably increased in ...

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certai...

Doximity Crushes The Rule Of 40 - Try Rule Of 58
I have a price target of $85 for Doximity by summer 2026. There is lots to be bullish about. Doximity's fundamentals are strong: zero debt, a large cash cushion, and robust free cash flow generation s...

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'
I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut...

Doximity to Present at the William Blair 45th Annual Growth Stock Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...

Doximity Stock 7.8% Higher After Key Trading Signal
DOCS reverses steep decline after TradePulse Alert

These Analysts Cut Their Forecasts On Doximity After Q4 Results
Doximity, Inc. DOCS reported better-than-expected earnings for the fourth quarter on Thursday.

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Fo...

Doximity Stock Drops 20% After Outlook Disappoints
Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ende...

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation
Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained m...

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ...

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. ...

Doximity: Rating Downgrade As Near-Term Upside Is Priced In
I downgraded Doximity from buy to hold due to expected growth slowdown and current high valuation at 40.5x forward EBITDA. DOCS reported strong Q3 performance with $168.6 million revenue, 25% y/y grow...

Doximity Momentum, Big Money Support Stays Strong
Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th ...

Doximity Q3 Earnings: Outpacing Even Management's Expectations
I previously rated Doximity, Inc. a buy due to strong Q2 earnings, favorable DCF analysis, and its strategic position in the healthcare industry. Q3 earnings showed continued strength, with DOCS stock...